Aptuit obtains the CEO Cancer Gold Standard accreditation

Aptuit, Inc. has received CEO Cancer Gold Standard^™ accreditation, recognizing the organization’s commitment to the health of their employees and family members by certifying their efforts to meet an exceptionally high standard of cancer prevention, screening and care guidelines.

William C. Weldon, chairman and chief executive officer of Johnson & Johnson chairs the CEO Roundtable on Cancer, the nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard^™, in collaboration with the National Cancer Institute, many of its designated cancer centers, the American Cancer Society, CDC and leading health professionals.

“Our Gold Standard certification acknowledges the personal leadership of Chairman and CEO Tim Tyson and recognizes that Aptuit’s efforts to improve health begin with the company’s own employees and their family members,” said Weldon.

The CEO Cancer Gold Standard^™, calls for companies to evaluate their benefits and culture and take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace. To earn Gold Standard accreditation, a company must establish programs to reduce cancer risk by discouraging tobacco use and encouraging physical activity, healthy diet and nutrition; detect cancer at its earliest stages; and provide access to quality care, including the availability of clinical trials.

Aptuit’s commitment to cancer prevention and employee health and wellness was inspired by Chairman and CEO, Timothy C. Tyson. Prior to joining Aptuit in 2008, Tyson served as COO, President and CEO of Valeant Pharmaceuticals International, a company he also helped lead to CEO Cancer Gold Standard accreditation.